Suppr超能文献

提高溶栓后冠状动脉再灌注的疗效和稳定性:探索凝血酶假说。

Improving the Efficacy and Stability of Coronary Reperfusion Following Thrombolysis: Exploring the Thrombin Hypothesis.

作者信息

Becker RC

机构信息

Thrombosis Research Center, University of Massachusetts Medical School, Worcester, MA.

出版信息

J Thromb Thrombolysis. 1995;1(2):133-144. doi: 10.1007/BF01062570.

Abstract

A major assumption in the treatment of patients with acute myocardial infarction (MI) implies that the speed of coronary arterial reperfusion correlates directly with the overall extent of myocardial salvage, and that the extent of mycardial salvage, in turn, determines the absolute reduction in patient mortality. While a growing experience has made it clear that myocardial salvage-independent (time-independent) mechanisms of benefit also exist, few would argue with the hypothesis that the greatest benefit derived from coronary thrombolysis occurs with early (time-dependent) treatment. Thus, improvements in the efficacy of reperfusion and the stability of reperfusion are likely to have considerable impact on patient outcome.

摘要

急性心肌梗死(MI)患者治疗中的一个主要假设是,冠状动脉再灌注的速度与心肌挽救的总体程度直接相关,而心肌挽救的程度反过来又决定了患者死亡率的绝对降低。虽然越来越多的经验表明,也存在与心肌挽救无关(与时间无关)的获益机制,但很少有人会反对这样的假设,即冠状动脉溶栓治疗的最大获益出现在早期(与时间有关)治疗中。因此,再灌注疗效的改善和再灌注的稳定性可能会对患者的预后产生相当大的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验